SGLT2 + GLP-1 =

Poll

Combination therapy with an SGLT2 inhibitor and GLP-1 receptor agonist:

A. Is safe and well tolerated
B. Achieves double the weight loss of a SGLT2 inhibitor alone
C. Is additive with respect to its effects on weight loss.
D. All of the above
E. None of the above
Related Videos
Should We Reclassify Diabetes Subtypes?
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
Daniel Gaudet, MD, PhD | Credit: American College of Cardiology
© 2024 MJH Life Sciences

All rights reserved.